MedCanHub: a platform developed by Cellen aimed at reducing barriers of access to unlicensed cannabis-based medicinal products during the COVID-19 pandemic.

Zong, Lim Zhen; Mawkin, Mala; Sharon, Haggai; Barnes, Michael; Pardalidis, Panagiotis; Marten, Sarah; Camilleri, Giancarlo; de Lesegno, Benjamin Viaris

Zong, Lim Zhen; Mawkin, Mala; Sharon, Haggai; Barnes, Michael; Pardalidis, Panagiotis; Marten, Sarah; Camilleri, Giancarlo; de Lesegno, Benjamin Viaris.

Afiliación

Zong LZ; Imperial College London, London, UK.
Mawkin M; Imperial College London, London, UK.
Sharon H; Guy's and St Thomas' Pain Management and Neuromodulation Centre, London, UK.
Barnes M; Medical Cannabis Clinician Society.
Pardalidis P; Imperial College London, London, UK.
Marten S; Cellen Life Sciences.
Camilleri G; Ashford and St Peter's NHS Foundation Trust, Surrey, UK.
de Lesegno BV; Cellen Life Sciences.

Clin Med (Lond) ; 21(Suppl 2): 29-30, 2021 Mar.

Article en En | MEDLINE | ID: mdl-34078686

Asunto(s)

COVID-19; Cannabis; Humanos; Pandemias; SARS-CoV-2; Encuestas y Cuestionarios

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cannabis / COVID-19 Límite: Humans Idioma: En Revista: Clin Med (Lond) Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google